ENHRX Mutual Fund

NAV$11.30

Fund Essentials - as of Mar 31, 2026

Net Assets
$6M
Expense Ratio
1.00%
Dividend Yield (Current)
5.43%
Holdings
44
Inception Date
Dec 15, 2015
Fund Family
Cullen Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Quarterly
SEC 30-Day Yield
PRO

Performance

YTD+8.49%
1 Year+12.54%
3 Year+8.29%
5 Year+6.47%
10 Year+7.23%

Asset Allocation

Stocks: 100.25%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
COPConocophilips4.98%
MRKMerck & Co. Inc.4.11%
CSCOCisco Systems Inc. - Ordinary Shares4.04%
MDT:IEMedtronic Plc4.01%
BMYBristol-Myers Squibb Co.3.89%
Top 10 Concentration: 38.63%Report Date: Mar 31, 2026
Download all 44 holdings for ENHRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
5.43%
Frequency
Quarterly
Latest Distribution
$0.16
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how ENHRX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$99/yr
7-day refund. Cancel anytime.
X-ray my whole portfolio
$99/yr Pro · 7-day refund. From MarketXLS, trusted since 2014.

ENHRX Mutual Fund Overview

ENHRX Mutual Fund (CULLEN ENHANCED EQUITY INCOME FUND Retail Class) is managed by Cullen Funds with $5.5M in net assets. ENHRX expense ratio is 1.00%, holding 44 positions across sectors including Health Care, Unknown, Energy. Inception date: 2015-12-15.

ENHRX performance shows a YTD return of 8.49%. The 1-year return is 12.54% and the 5-year return is 6.47%. ENHRX dividend yield stands at 5.43%, paid quarterly.

ENHRX top holdings include Conocophilips (5.0%), Merck & Co. Inc. (4.1%), Cisco Systems Inc. - Ordinary Shares (4.0%), Medtronic Plc (4.0%), Bristol-Myers Squibb Co. (3.9%). View all ENHRX holdings, sector breakdown, or dividend history.

ENHRX can be compared against other funds using the overlap calculator or side-by-side comparison tool. ENHRX alternatives are available via the screener, along with tax-loss harvesting opportunities.